Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CFO Lee Kalowski Sells 1,301 Shares of Company Stock

Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CFO Lee Kalowski sold 1,301 shares of Leverage Shares 2X Long FIX Daily ETF stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $8.32, for a total value of $10,824.32. Following the sale, the chief financial officer directly owned 137,170 shares of the company’s stock, valued at approximately $1,141,254.40. This trade represents a 0.94% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Lee Kalowski also recently made the following trade(s):

• On Tuesday, August 25th, Lee Kalowski sold 3,972 shares of Leverage Shares 2X Long FIX Daily ETF stock. The stock was sold at an average price of $16.56, for a total value of $65,776.32.

Leverage Shares 2X Long FIX Daily ETF Price Performance

FIXX opened at $11.01 on Thursday. Leverage Shares 2X Long FIX Daily ETF has a 12-month low of $11.00 and a 12-month high of $15.92.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.